HEADER TRANSFERASE 30-JUN-03 1OJ4 TITLE TERNARY COMPLEX OF 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CMK, 4-(CYTIDINE-5'-DIPHOSPHO)-2-C-METHYL-D -ERYTHRITOL COMPND 5 KINASE; COMPND 6 EC: 2.7.1.148; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 217992; SOURCE 4 STRAIN: O6; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET15B KEYWDS TRANSFERASE, KINASE, ISOPRENOIDS BIOSYNTHESIS, GHMP KINASE KEYWDS 2 SUPERFAMILY TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.MIALLAU,M.S.ALPHEY,W.N.HUNTER REVDAT 6 16-OCT-19 1OJ4 1 REMARK LINK REVDAT 5 24-FEB-09 1OJ4 1 VERSN REVDAT 4 29-JUL-04 1OJ4 1 HETNAM REVDAT 3 13-AUG-03 1OJ4 1 FORMUL REVDAT 2 07-AUG-03 1OJ4 1 JRNL REVDAT 1 31-JUL-03 1OJ4 0 JRNL AUTH L.MIALLAU,M.S.ALPHEY,L.E.KEMP,G.A.LEONARD,S.M.MCSWEENEY, JRNL AUTH 2 S.HECHT,A.BACHER,W.EISENREICH,F.ROHDICH,W.N.HUNTER JRNL TITL BIOSYNTHESIS OF ISOPRENOIDS: CRYSTAL STRUCTURE OF JRNL TITL 2 4-DIPHOSPHOCYTIDYL-2C-METHYL-D-ERYTHRITOL KINASE JRNL REF PROC.NATL.ACAD.SCI.USA V. 100 9173 2003 JRNL REFN ISSN 0027-8424 JRNL PMID 12878729 JRNL DOI 10.1073/PNAS.1533425100 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 39761 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1972 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4357 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 383 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.37000 REMARK 3 B22 (A**2) : -0.14000 REMARK 3 B33 (A**2) : -0.61000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.61000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.185 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.400 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: FURTHER REFINEMENTS SHOWED A SINGLE REMARK 3 CONFORMATION OF THE GAMMA-PHOSHATE IN THE A-SUBUNIT REMARK 4 REMARK 4 1OJ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1290012686. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : SI(311) REMARK 200 OPTICS : LENSES REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39761 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 5.580 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.14700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: SOLVE/RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % POLYETHYLENE GLYCOL 8000 0.2 M REMARK 280 MAGNESUIM ACTETATE, 0.1M SODIUM CACODYLATE PH 6.5 20MM REMARK 280 SULFOBETAIN, PH 6.50, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.15000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYTIC ACTIVITY: ATP + 4-(CYTIDINE 5'-DIPHOSPHO)-2-C REMARK 400 -METHYL-D-ERYTHRITOL = ADP + 2-PHOSPHO-4-(CYTIDINE 5'- REMARK 400 DIPHOSPHO)-2-C-METHYL-D-ERYTHRITOL. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MSE B 128 CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2036 O HOH B 2115 1.82 REMARK 500 N MSE B 1 O HOH B 2002 1.97 REMARK 500 N GLY A 105 O1G ANP A 1285 2.09 REMARK 500 O ALA B 22 O HOH B 2021 2.11 REMARK 500 O HOH B 2067 O HOH B 2155 2.12 REMARK 500 O HOH B 2036 O HOH B 2113 2.15 REMARK 500 O HOH B 2144 O HOH B 2161 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2096 O HOH B 2135 2645 1.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 47 CB - CG - OD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 ASP B 36 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 47 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 37 139.59 -173.39 REMARK 500 GLU A 58 116.46 -35.05 REMARK 500 GLU A 154 -166.96 -129.94 REMARK 500 TYR B 37 140.23 -170.62 REMARK 500 GLU B 58 114.37 -31.39 REMARK 500 ALA B 90 143.00 -170.31 REMARK 500 GLU B 154 -164.17 -117.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ANP A 1285 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDM A1284 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A1285 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDM B1284 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP B1285 DBREF 1OJ4 A 1 283 UNP Q8FI04 ISPE_ECOL6 1 283 DBREF 1OJ4 B 1 283 UNP Q8FI04 ISPE_ECOL6 1 283 SEQADV 1OJ4 PRO A 85 UNP Q8FI04 SER 85 CONFLICT SEQADV 1OJ4 THR A 161 UNP Q8FI04 MET 161 CONFLICT SEQADV 1OJ4 PRO B 85 UNP Q8FI04 SER 85 CONFLICT SEQADV 1OJ4 THR B 161 UNP Q8FI04 MET 161 CONFLICT SEQRES 1 A 283 MSE ARG THR GLN TRP PRO SER PRO ALA LYS LEU ASN LEU SEQRES 2 A 283 PHE LEU TYR ILE THR GLY GLN ARG ALA ASP GLY TYR HIS SEQRES 3 A 283 THR LEU GLN THR LEU PHE GLN PHE LEU ASP TYR GLY ASP SEQRES 4 A 283 THR ILE SER ILE GLU LEU ARG ASP ASP GLY ASP ILE ARG SEQRES 5 A 283 LEU LEU THR PRO VAL GLU GLY VAL GLU HIS GLU ASP ASN SEQRES 6 A 283 LEU ILE VAL ARG ALA ALA ARG LEU LEU MSE LYS THR ALA SEQRES 7 A 283 ALA ASP SER GLY ARG LEU PRO THR GLY SER GLY ALA ASN SEQRES 8 A 283 ILE SER ILE ASP LYS ARG LEU PRO MSE GLY GLY GLY LEU SEQRES 9 A 283 GLY GLY GLY SER SER ASN ALA ALA THR VAL LEU VAL ALA SEQRES 10 A 283 LEU ASN HIS LEU TRP GLN CYS GLY LEU SER MSE ASP GLU SEQRES 11 A 283 LEU ALA GLU MSE GLY LEU THR LEU GLY ALA ASP VAL PRO SEQRES 12 A 283 VAL PHE VAL ARG GLY HIS ALA ALA PHE ALA GLU GLY VAL SEQRES 13 A 283 GLY GLU ILE LEU THR PRO VAL ASP PRO PRO GLU LYS TRP SEQRES 14 A 283 TYR LEU VAL ALA HIS PRO GLY VAL SER ILE PRO THR PRO SEQRES 15 A 283 VAL ILE PHE LYS ASP PRO GLU LEU PRO ARG ASN THR PRO SEQRES 16 A 283 LYS ARG SER ILE GLU THR LEU LEU LYS CYS GLU PHE SER SEQRES 17 A 283 ASN ASP CYS GLU VAL ILE ALA ARG LYS ARG PHE ARG GLU SEQRES 18 A 283 VAL ASP ALA VAL LEU SER TRP LEU LEU GLU TYR ALA PRO SEQRES 19 A 283 SER ARG LEU THR GLY THR GLY ALA CYS VAL PHE ALA GLU SEQRES 20 A 283 PHE ASP THR GLU SER GLU ALA ARG GLN VAL LEU GLU GLN SEQRES 21 A 283 ALA PRO GLU TRP LEU ASN GLY PHE VAL ALA LYS GLY VAL SEQRES 22 A 283 ASN LEU SER PRO LEU HIS ARG ALA MSE LEU SEQRES 1 B 283 MSE ARG THR GLN TRP PRO SER PRO ALA LYS LEU ASN LEU SEQRES 2 B 283 PHE LEU TYR ILE THR GLY GLN ARG ALA ASP GLY TYR HIS SEQRES 3 B 283 THR LEU GLN THR LEU PHE GLN PHE LEU ASP TYR GLY ASP SEQRES 4 B 283 THR ILE SER ILE GLU LEU ARG ASP ASP GLY ASP ILE ARG SEQRES 5 B 283 LEU LEU THR PRO VAL GLU GLY VAL GLU HIS GLU ASP ASN SEQRES 6 B 283 LEU ILE VAL ARG ALA ALA ARG LEU LEU MSE LYS THR ALA SEQRES 7 B 283 ALA ASP SER GLY ARG LEU PRO THR GLY SER GLY ALA ASN SEQRES 8 B 283 ILE SER ILE ASP LYS ARG LEU PRO MSE GLY GLY GLY LEU SEQRES 9 B 283 GLY GLY GLY SER SER ASN ALA ALA THR VAL LEU VAL ALA SEQRES 10 B 283 LEU ASN HIS LEU TRP GLN CYS GLY LEU SER MSE ASP GLU SEQRES 11 B 283 LEU ALA GLU MSE GLY LEU THR LEU GLY ALA ASP VAL PRO SEQRES 12 B 283 VAL PHE VAL ARG GLY HIS ALA ALA PHE ALA GLU GLY VAL SEQRES 13 B 283 GLY GLU ILE LEU THR PRO VAL ASP PRO PRO GLU LYS TRP SEQRES 14 B 283 TYR LEU VAL ALA HIS PRO GLY VAL SER ILE PRO THR PRO SEQRES 15 B 283 VAL ILE PHE LYS ASP PRO GLU LEU PRO ARG ASN THR PRO SEQRES 16 B 283 LYS ARG SER ILE GLU THR LEU LEU LYS CYS GLU PHE SER SEQRES 17 B 283 ASN ASP CYS GLU VAL ILE ALA ARG LYS ARG PHE ARG GLU SEQRES 18 B 283 VAL ASP ALA VAL LEU SER TRP LEU LEU GLU TYR ALA PRO SEQRES 19 B 283 SER ARG LEU THR GLY THR GLY ALA CYS VAL PHE ALA GLU SEQRES 20 B 283 PHE ASP THR GLU SER GLU ALA ARG GLN VAL LEU GLU GLN SEQRES 21 B 283 ALA PRO GLU TRP LEU ASN GLY PHE VAL ALA LYS GLY VAL SEQRES 22 B 283 ASN LEU SER PRO LEU HIS ARG ALA MSE LEU MODRES 1OJ4 MSE A 1 MET SELENOMETHIONINE MODRES 1OJ4 MSE A 75 MET SELENOMETHIONINE MODRES 1OJ4 MSE A 100 MET SELENOMETHIONINE MODRES 1OJ4 MSE A 128 MET SELENOMETHIONINE MODRES 1OJ4 MSE A 134 MET SELENOMETHIONINE MODRES 1OJ4 MSE A 282 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 1 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 75 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 100 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 128 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 134 MET SELENOMETHIONINE MODRES 1OJ4 MSE B 282 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 75 8 HET MSE A 100 8 HET MSE A 128 8 HET MSE A 134 8 HET MSE A 282 8 HET MSE B 1 8 HET MSE B 75 8 HET MSE B 100 8 HET MSE B 128 10 HET MSE B 134 8 HET MSE B 282 8 HET CDM A1284 33 HET ANP A1285 30 HET CL A1286 1 HET CDM B1284 33 HET ANP B1285 31 HETNAM MSE SELENOMETHIONINE HETNAM CDM 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM CL CHLORIDE ION FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 CDM 2(C14 H25 N3 O14 P2) FORMUL 4 ANP 2(C10 H17 N6 O12 P3) FORMUL 5 CL CL 1- FORMUL 8 HOH *383(H2 O) HELIX 1 1 GLU A 61 ASP A 64 5 4 HELIX 2 2 ASN A 65 SER A 81 1 17 HELIX 3 3 GLY A 105 TRP A 122 1 18 HELIX 4 4 SER A 127 LEU A 136 1 10 HELIX 5 5 THR A 137 GLY A 139 5 3 HELIX 6 6 ASP A 141 GLY A 148 1 8 HELIX 7 7 PRO A 180 LYS A 186 1 7 HELIX 8 8 SER A 198 CYS A 205 1 8 HELIX 9 9 CYS A 211 PHE A 219 1 9 HELIX 10 10 PHE A 219 LEU A 230 1 12 HELIX 11 11 THR A 250 ALA A 261 1 12 HELIX 12 12 PRO A 262 ASN A 266 5 5 HELIX 13 13 SER A 276 ALA A 281 1 6 HELIX 14 14 GLU B 61 ASP B 64 5 4 HELIX 15 15 ASN B 65 SER B 81 1 17 HELIX 16 16 GLY B 105 TRP B 122 1 18 HELIX 17 17 ASP B 129 GLY B 139 1 11 HELIX 18 18 ASP B 141 GLY B 148 1 8 HELIX 19 19 PRO B 180 LYS B 186 1 7 HELIX 20 20 SER B 198 CYS B 205 1 8 HELIX 21 21 CYS B 211 PHE B 219 1 9 HELIX 22 22 PHE B 219 GLU B 231 1 13 HELIX 23 23 THR B 250 ALA B 261 1 12 HELIX 24 24 PRO B 262 ASN B 266 5 5 HELIX 25 25 SER B 276 ALA B 281 1 6 SHEET 1 AA 4 ARG A 2 GLN A 20 0 SHEET 2 AA 4 HIS A 26 ARG A 46 -1 O THR A 27 N THR A 18 SHEET 3 AA 4 ALA A 151 GLU A 154 -1 O ALA A 151 N PHE A 32 SHEET 4 AA 4 ILE A 159 PRO A 162 -1 O ILE A 159 N GLU A 154 SHEET 1 AB 6 ARG A 2 GLN A 20 0 SHEET 2 AB 6 HIS A 26 ARG A 46 -1 O THR A 27 N THR A 18 SHEET 3 AB 6 PHE A 268 VAL A 273 -1 O LYS A 271 N ASP A 36 SHEET 4 AB 6 TRP A 169 ALA A 173 -1 O TYR A 170 N ALA A 270 SHEET 5 AB 6 VAL A 244 PHE A 248 -1 O VAL A 244 N ALA A 173 SHEET 6 AB 6 SER A 235 LEU A 237 -1 O ARG A 236 N PHE A 245 SHEET 1 BA 4 THR B 3 GLN B 20 0 SHEET 2 BA 4 HIS B 26 ARG B 46 -1 O THR B 27 N THR B 18 SHEET 3 BA 4 ALA B 151 GLU B 154 -1 O ALA B 151 N PHE B 32 SHEET 4 BA 4 ILE B 159 PRO B 162 -1 O ILE B 159 N GLU B 154 SHEET 1 BB 6 THR B 3 GLN B 20 0 SHEET 2 BB 6 HIS B 26 ARG B 46 -1 O THR B 27 N THR B 18 SHEET 3 BB 6 PHE B 268 VAL B 273 -1 O LYS B 271 N ASP B 36 SHEET 4 BB 6 TRP B 169 ALA B 173 -1 O TYR B 170 N ALA B 270 SHEET 5 BB 6 VAL B 244 PHE B 248 -1 O VAL B 244 N ALA B 173 SHEET 6 BB 6 SER B 235 LEU B 237 -1 O ARG B 236 N PHE B 245 LINK C MSE A 1 N ARG A 2 1555 1555 1.32 LINK C LEU A 74 N MSE A 75 1555 1555 1.33 LINK C MSE A 75 N LYS A 76 1555 1555 1.32 LINK C PRO A 99 N MSE A 100 1555 1555 1.32 LINK C MSE A 100 N GLY A 101 1555 1555 1.33 LINK C SER A 127 N MSE A 128 1555 1555 1.34 LINK C MSE A 128 N ASP A 129 1555 1555 1.33 LINK C GLU A 133 N MSE A 134 1555 1555 1.33 LINK C MSE A 134 N GLY A 135 1555 1555 1.34 LINK C ALA A 281 N MSE A 282 1555 1555 1.33 LINK C MSE A 282 N LEU A 283 1555 1555 1.33 LINK C MSE B 1 N ARG B 2 1555 1555 1.33 LINK C LEU B 74 N MSE B 75 1555 1555 1.33 LINK C MSE B 75 N LYS B 76 1555 1555 1.33 LINK C PRO B 99 N MSE B 100 1555 1555 1.33 LINK C MSE B 100 N GLY B 101 1555 1555 1.33 LINK C SER B 127 N MSE B 128 1555 1555 1.33 LINK C MSE B 128 N ASP B 129 1555 1555 1.33 LINK C GLU B 133 N MSE B 134 1555 1555 1.33 LINK C MSE B 134 N GLY B 135 1555 1555 1.33 LINK C ALA B 281 N MSE B 282 1555 1555 1.33 LINK C MSE B 282 N LEU B 283 1555 1555 1.33 CISPEP 1 GLY A 241 ALA A 242 0 3.87 CISPEP 2 GLY B 241 ALA B 242 0 2.66 SITE 1 AC1 3 ARG A 147 HOH A2095 HOH A2096 SITE 1 AC2 21 LYS A 10 ASN A 12 GLY A 24 TYR A 25 SITE 2 AC2 21 HIS A 26 GLY A 139 ALA A 140 ASP A 141 SITE 3 AC2 21 VAL A 156 THR A 181 PHE A 185 ANP A1285 SITE 4 AC2 21 HOH A2093 HOH A2101 HOH A2184 HOH A2185 SITE 5 AC2 21 HOH A2186 HOH A2187 HOH A2188 HOH A2189 SITE 6 AC2 21 HOH A2190 SITE 1 AC3 21 LYS A 10 VAL A 60 ASN A 65 LEU A 66 SITE 2 AC3 21 LYS A 96 MSE A 100 GLY A 101 GLY A 102 SITE 3 AC3 21 GLY A 103 LEU A 104 GLY A 105 GLY A 106 SITE 4 AC3 21 GLY A 107 SER A 108 ASN A 110 CDM A1284 SITE 5 AC3 21 HOH A2068 HOH A2184 HOH A2188 HOH A2190 SITE 6 AC3 21 HOH A2192 SITE 1 AC4 21 LYS B 10 ASN B 12 GLY B 24 TYR B 25 SITE 2 AC4 21 HIS B 26 LEU B 28 PHE B 32 SER B 108 SITE 3 AC4 21 ALA B 140 ASP B 141 VAL B 156 THR B 181 SITE 4 AC4 21 PHE B 185 THR B 240 ANP B1285 HOH B2104 SITE 5 AC4 21 HOH B2186 HOH B2187 HOH B2188 HOH B2189 SITE 6 AC4 21 HOH B2190 SITE 1 AC5 18 ASP B 64 ASN B 65 LEU B 66 LYS B 96 SITE 2 AC5 18 PRO B 99 MSE B 100 GLY B 101 GLY B 103 SITE 3 AC5 18 LEU B 104 GLY B 105 GLY B 106 GLY B 107 SITE 4 AC5 18 SER B 108 ASN B 110 CDM B1284 HOH B2189 SITE 5 AC5 18 HOH B2190 HOH B2191 CRYST1 61.000 76.300 68.600 90.00 107.80 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016393 0.000000 0.005263 0.00000 SCALE2 0.000000 0.013106 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015310 0.00000 HETATM 1 N MSE A 1 5.371 41.635 18.962 1.00 30.82 N HETATM 2 CA MSE A 1 4.916 40.205 18.855 1.00 30.57 C HETATM 3 C MSE A 1 6.045 39.215 19.146 1.00 28.61 C HETATM 4 O MSE A 1 7.164 39.373 18.664 1.00 28.51 O HETATM 5 CB MSE A 1 4.352 39.897 17.462 1.00 31.30 C HETATM 6 CG MSE A 1 3.198 40.783 17.000 1.00 37.02 C HETATM 7 SE MSE A 1 1.526 40.428 17.942 1.00 42.68 SE HETATM 8 CE MSE A 1 1.324 42.176 18.858 1.00 41.42 C